When Recalls Fail — The Gap Between Notification and Action

Medical device recalls are intended to act as a hard stop. When a defect is identified, products are removed from use, hospitals are notified, and patients are protected. At least, that is how the system is designed to work.

A well-documented implantable device recall, and the events that followed, reveals a more troubling reality. The failure was not the absence of a recall or the concealment of risk. The failure was execution. Devices that had already been recalled were not fully removed from clinical inventory and were later implanted in patients months after the recall took effect.

This is not a story about a single manufacturer or hospital. It is a case study in how recall execution breaks down across today’s fragmented healthcare supply chain. The purpose of examining this case is not to assign blame, but to expose a systemic vulnerability that emerges when recall processes rely on manual, disconnected systems. The perspective offered here draws from direct experience working with healthcare providers, manufacturers, and distributors on recall execution and post-market surveillance.

In May 2018, the manufacturer of the LINX Reflux Management System initiated an FDA Class II recall. The issue was serious but specific: certain devices were at risk of bead separation or fracture due to a manufacturing defect. Potential consequences included pain, difficulty swallowing, erosion, and the need for surgical removal.

Thousands of devices had already been distributed. Hospitals and providers were instructed to identify affected units, quarantine them, and immediately stop implantation.

On paper, that should have been the end of the story; this is how recall execution is supposed to work across the healthcare system. According to multiple lawsuits and subsequent reporting, it was not.

A lawsuit filed in early 2026 alleges that a patient was implanted with a recalled device in December 2018 — approximately seven months after the recall had been issued. The complaint asserts that the implanted unit was subject to the recall and later failed, ultimately requiring surgical removal in 2025. Other federal court filings describe similar timelines. 

These cases do not claim that the recall never occurred. They allege something more troubling: recalled implants were never fully removed from hospital and consignment inventory, remained available for clinical use, and were selected for implantation long after the recall was already in effect. For patients, the consequences are profound.

Being implanted with a recalled device can mean years of pain, functional impairment, and the burden of an additional invasive surgery to remove something that should never have been implanted in the first place. Explant procedures are often more complex than initial implantations, carrying higher risks due to scar tissue, inflammation, and altered anatomy.

For patients in these cases, the recall failed to protect them — not because it came too late, but because it stopped at notification and never fully translated into action.

Where the system broke down

The legal filings point to a familiar pattern in healthcare recall management:

• Recall notices were issued but not fully operationalized within hospitals
• Recalled devices remained in inventory, including consignment stock
• There was no real-time link between recall status and surgical use
• Providers and supply chain teams lacked a single system of record to confirm what was safe to implant

In plain terms, the system depended on people to manually connect too many dots across too many disconnected systems, often under real-world clinical pressure.

That is how a recalled implant can still end up in an operating room months after a recall is issued.

This is a systems problem, not a people problem

While these lawsuits stand out because they involve implantable devices and named patients, the underlying failure is not unique.

Today, recalls are still managed through paper letters, emails, spreadsheets, and siloed databases. When a recall is issued, hospitals rarely have immediate certainty about whether affected products are actually on their shelves. Clinical and supply chain teams are forced into a manual process: pulling reports, checking physical inventory, tracing lot and batch numbers, and reconciling recall notices against stock that may already be moving.

Even when teams act quickly and in good faith, this approach leaves room for error. Recalled products can remain available not because staff failed, but because the system requires them to prove the absence of risk across fragmented data sources.

As recall volume and complexity have increased over the past decade, that burden has increased — consuming enormous time while still failing to eliminate gaps.

Without a direct, networked connection between manufacturers, distributors, and providers, hospitals lack:

• A centralized way to track recalls across suppliers
• A reliable method to link recall notices to actual inventory and patient exposure
• Confidence that recalled products have been fully identified and removed

This is not a reflection of effort or intent. It is a structural limitation of the tools in use today, and it creates a patient safety gap that manual processes cannot reliably close.

What a networked recall model enables

In a networked recall system, the goal is straightforward but ambitious: ensure that recalls cannot exist only as notices. Instead, they become actionable, trackable, auditable events that connect manufacturers, distributors, providers, inventory, and patients within a single system.

In a networked recall system:

• Recalled devices are matched against actual received inventory, not assumptions
• Providers see recall status in one authoritative record
• Expanded or updated recalls remain unified rather than splintering into alerts
• Patient exposure can be assessed faster and with greater confidence

Most importantly, recalled products are far less likely to slip through the cracks.

These cases are not about one device or one manufacturer. They illustrate what happens when recall intent and recall execution diverge.

Patients and surgeons assume recalls immediately stop use. Regulators assume notices translate into action. Lawsuits like these arise in the space between those assumptions. That space is where recall execution most often fails.

Shared responsibility requires shared infrastructure

The lesson from these post-recall implantation allegations is not about assigning fault. It is about recognizing that recall execution fails at the seams — between organizations, systems, and handoffs.

Manufacturers can issue timely, compliant recalls and still lack visibility into whether products were removed from inventory. Providers can act in good faith and still struggle to reconcile fragmented notices against real inventory and clinical use.

That seam is where shared recall infrastructure becomes essential. It provides shared infrastructure and a single source of truth for recall communication, acknowledgment, and action. When manufacturers and providers work from the same authoritative record, recalls stop being passive notifications and become coordinated, auditable interventions — protecting patients.

Photo: Aquir, Getty Images

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.